The latest board meeting for Adc Therapeutics SA took place on 21 May 2025, for the purpose of RBC Capital Markets Global Healthcare ConferenceSee details
Adc Therapeutics SA - ADCT - stock price prediction, stock price target, analyst ratings from 6 analysts
Adc Therapeutics SA has a share price target of US$ 8, revenue growth forecast of 9.4%, and profit growth estimate of -10.9% for FY25, based on top 6 analyst calls.